P J Loehrer
Overview
Explore the profile of P J Loehrer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
1520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ermel A, Tonui P, Titus M, Tong Y, Wong N, Ongecha J, et al.
BMC Infect Dis
. 2019 Apr;
19(1):352.
PMID: 31029097
Background: Cervical cancer is caused by oncogenic human papillomaviruses (HPV) and is one of the most common malignancies in women living in sub-Saharan Africa. Women infected with the human immunodeficiency...
2.
Strother R, Fitch M, Kamau P, Beattie K, Boudreau A, Busakhalla N, et al.
Support Care Cancer
. 2012 May;
20(9):2211-5.
PMID: 22565597
Cancer is a rising cause of morbidity and mortality in resource-constrained settings. Few places in the developing world have cancer care experts and infrastructure for caring for cancer patients; therefore,...
3.
Witte R, Elson P, Stewart J, Malliard J, Oken M, Loehrer P
Urol Oncol
. 2011 Jan;
2(3):96-8.
PMID: 21224145
Sixty-one ambulatory patients with advanced or unresectable renal carcinoma were treated with either melphalan (41 patients) or thioguanine (20 patients). Two objective partial responses were observed in the melphalan cohorts...
4.
Jung C, Kim R, Zhang H, Lee S, Sheng H, Loehrer P, et al.
Br J Cancer
. 2005 Jun;
92(12):2233-9.
PMID: 15928669
Mutations in the Wnt signalling cascade are believed to cause aberrant proliferation of colorectal cells through T-cell factor-4 (TCF4) and its downstream growth-modulating factors. HOXB13 is exclusively expressed in prostate...
5.
Shirao K, Hoff P, Ohtsu A, Loehrer P, Hyodo I, Wadler S, et al.
J Clin Oncol
. 2004 Jul;
22(17):3466-74.
PMID: 15277535
Purpose: To compare the efficacy, toxicities, and pharmacokinetics of an oral regimen consisting of uracil/tegafur (UFT) and leucovorin (LV) between Japanese patients and patients in the United States with previously...
6.
John W, Picus J, Blanke C, Clark J, Schulman L, Rowinsky E, et al.
Cancer
. 2000 Apr;
88(8):1807-13.
PMID: 10760756
Background: The aim of this study was to confirm the activity and assess the safety profile of multitargeted antifolate (MTA) for patients with metastatic colorectal adenocarcinoma. Methods: Forty-six patients were...
7.
Ganjoo K, Loyal J, Cramer H, Loehrer P
J Clin Oncol
. 1999 Nov;
17(9):2995-7.
PMID: 10561377
No abstract available.
8.
Thomas C, Wright C, Loehrer P
J Clin Oncol
. 1999 Nov;
17(7):2280-9.
PMID: 10561285
Thymoma is the most common tumor of the anterior mediastinum. This tumor is associated with unique paraneoplastic syndromes, such as myasthenia gravis, hypogammaglobulinemia, and pure red cell aplasia. The rarity...
9.
Eisenberger M, Blumenstein B, Crawford E, Miller G, McLeod D, Loehrer P, et al.
N Engl J Med
. 1998 Oct;
339(15):1036-42.
PMID: 9761805
Background: Combined androgen blockade for the treatment of metastatic prostate cancer consists of an antiandrogen drug plus castration. In a previous trial, we found that adding the antiandrogen flutamide to...
10.
Bandealy M, GONIN R, Loehrer P, Monaco F, Einhorn L
Clin Cancer Res
. 1998 May;
4(4):935-9.
PMID: 9563887
The purpose of this study was to compare the objective response rate, duration of remission, and survival of 5-fluorouracil (5-FU) versus those of 5-FU plus levamisole in metastatic colorectal cancer...